BSE filing, NSE: QUEST. Summary written from the filing by ALFA Finder's alert engine.
Ampvolts Ltd: key numbers
- Share price
- ₹22.82
- Market cap
- ₹58.96 Cr
- Revenue (annual)
- ₹20.64 Cr
- Net profit (annual)
- ₹1.55 Cr
- P/E (TTM)
- 19.8×Sector 22.9×
- Promoter holding
- 55.25%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ampvolts Ltd
All →Ampvolts Other Announcement
Ampvolts Ltd has submitted its quarterly shareholding pattern statement for the period ending September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Ampvolts Management Change
Ampvolts Limited has appointed M/s. MYSP & Associates LLP as its Statutory Auditor for a 60-month term. The firm brings over 34 years of experience in audit and consultancy.
- Execution
- 60 months
Ampvolts Other Announcement
Ampvolts Limited has appointed M/s. MYSP & Associates LLP as Statutory Auditors for a five-year term. The appointment is effective from the 27th Annual General Meeting.
- Execution
- 5 years
Ampvolts Annual General Meeting
Ampvolts Limited held its 27th Annual General Meeting on September 30, 2026. The meeting covered standard agenda items, including financial statement adoption and statutory auditor appointment.
Ampvolts Annual Report
Ampvolts Limited has filed its Annual Report for the financial year 2025-26, including the notice for its 27th Annual General Meeting.
Ampvolts Annual General Meeting
Ampvolts Limited issued the notice for its 27th Annual General Meeting, scheduled to be held on September 30, 2026, through video conferencing.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.